Compare PSIX & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSIX | ATRC |
|---|---|---|
| Founded | 1985 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | N/A | 2005 |
| Metric | PSIX | ATRC |
|---|---|---|
| Price | $56.01 | $39.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $98.76 | $52.22 |
| AVG Volume (30 Days) | 431.2K | ★ 488.6K |
| Earning Date | 02-08-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.27 | N/A |
| EPS | ★ 5.26 | N/A |
| Revenue | ★ $675,481,000.00 | $518,304,999.00 |
| Revenue This Year | $50.35 | $16.90 |
| Revenue Next Year | $20.10 | $12.25 |
| P/E Ratio | $11.25 | ★ N/A |
| Revenue Growth | ★ 54.78 | 15.80 |
| 52 Week Low | $18.10 | $28.29 |
| 52 Week High | $121.78 | $43.11 |
| Indicator | PSIX | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 37.54 | 52.77 |
| Support Level | $61.86 | $40.11 |
| Resistance Level | $69.90 | $41.33 |
| Average True Range (ATR) | 3.69 | 1.11 |
| MACD | -0.34 | -0.31 |
| Stochastic Oscillator | 0.43 | 2.63 |
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.